This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.
Bristol Myers Squibb’s Cell Therapy 360® program supports patients and caregivers throughout their treatment journey, from enrollment through the initial post-infusion monitoring period, with referral resources, patient support navigators, logistical support*, financial support*, and wearable technology for post-infusion monitoring.
*Eligibility requirements may apply.
Patients can receive a disposable wearable technology during the initial post-infusion monitoring period to help track their temperature in real time through their smartphone when outside the treatment center.
Patients are instructed to call their healthcare provider or go to the hospital if their temperature is 100.4°F/38°C or higher.
CAR=chimeric antigen receptor.